A detailed history of Xponance, Inc. transactions in Inspire Medical Systems, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 3,742 shares of INSP stock, worth $713,636. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,742
Previous 3,924 4.64%
Holding current value
$713,636
Previous $525,000 50.29%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$125.79 - $216.71 $22,893 - $39,441
-182 Reduced 4.64%
3,742 $789,000
Q2 2024

Aug 14, 2024

BUY
$133.83 - $251.19 $27,970 - $52,498
209 Added 5.63%
3,924 $525,000
Q1 2024

May 13, 2024

SELL
$165.3 - $226.0 $25,456 - $34,804
-154 Reduced 3.98%
3,715 $797,000
Q4 2023

Jan 31, 2024

SELL
$125.26 - $203.83 $28,434 - $46,269
-227 Reduced 5.54%
3,869 $787,000
Q3 2023

Oct 23, 2023

BUY
$185.0 - $326.08 $16,280 - $28,695
88 Added 2.2%
4,096 $812,000
Q2 2023

Jul 13, 2023

BUY
$226.52 - $324.64 $514,200 - $736,932
2,270 Added 130.61%
4,008 $1.3 Million
Q1 2023

Apr 17, 2023

BUY
$229.06 - $278.01 $6,871 - $8,340
30 Added 1.76%
1,738 $406,000
Q4 2022

Jan 23, 2023

BUY
$164.02 - $259.76 $3,280 - $5,195
20 Added 1.18%
1,708 $0
Q3 2022

Oct 24, 2022

BUY
$170.68 - $226.46 $10,411 - $13,814
61 Added 3.75%
1,688 $300,000
Q2 2022

Aug 02, 2022

BUY
$147.53 - $266.6 $27,440 - $49,587
186 Added 12.91%
1,627 $297,000
Q1 2022

Apr 20, 2022

BUY
$193.94 - $261.91 $2,133 - $2,881
11 Added 0.77%
1,441 $370,000
Q4 2021

Jan 31, 2022

BUY
$207.57 - $280.17 $1,660 - $2,241
8 Added 0.56%
1,430 $329,000
Q3 2021

Nov 05, 2021

SELL
$170.0 - $258.58 $36,890 - $56,111
-217 Reduced 13.24%
1,422 $331,000
Q2 2021

Aug 12, 2021

BUY
$164.93 - $242.23 $270,320 - $397,014
1,639 New
1,639 $317,000

Others Institutions Holding INSP

About Inspire Medical Systems, Inc.


  • Ticker INSP
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 28,788,600
  • Market Cap $5.49B
  • Description
  • Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...
More about INSP
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.